These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 16569424

  • 1. Outcomes of women with metachronous breast and ovarian carcinomas.
    Liou WS, Hamilton CA, Cheung MK, Osann K, Longacre TA, Teng NN, Husain A, Dirbas FM, Chan JK.
    Gynecol Oncol; 2006 Oct; 103(1):190-4. PubMed ID: 16569424
    [Abstract] [Full Text] [Related]

  • 2. Second primary ovarian cancer among women diagnosed previously with cancer.
    Hall HI, Jamison P, Weir HK.
    Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):995-9. PubMed ID: 11535553
    [Abstract] [Full Text] [Related]

  • 3. Breast cancer risk factors and second primary malignancies among women with breast cancer.
    Trentham-Dietz A, Newcomb PA, Nichols HB, Hampton JM.
    Breast Cancer Res Treat; 2007 Oct; 105(2):195-207. PubMed ID: 17186360
    [Abstract] [Full Text] [Related]

  • 4. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers.
    Chan JK, Teoh D, Hu JM, Shin JY, Osann K, Kapp DS.
    Gynecol Oncol; 2008 Jun; 109(3):370-6. PubMed ID: 18395777
    [Abstract] [Full Text] [Related]

  • 5. Analysis of the time interval between diagnoses in women with double primary breast and ovarian or primary peritoneal cancers.
    Olawaiye A, Caesar L, Walsh D, Lyman M, Yeh J, Rodabaugh K, Marchetti D, Lele S, Odunsi K.
    Gynecol Oncol; 2004 Sep; 94(3):796-802. PubMed ID: 15350375
    [Abstract] [Full Text] [Related]

  • 6. Epithelial ovarian cancer and low malignant potential (LMP) tumors associated with a lower incidence of second primary breast cancer.
    Hunter MI, Ziogas A, Flores F, Brewster WR.
    Am J Clin Oncol; 2007 Feb; 30(1):1-7. PubMed ID: 17278887
    [Abstract] [Full Text] [Related]

  • 7. Patients with a history of epithelial ovarian cancer presenting with a breast and/or axillary mass.
    Karam AK, Stempel M, Barakat RR, Morrow M, Gemignani ML.
    Gynecol Oncol; 2009 Mar; 112(3):490-5. PubMed ID: 19101713
    [Abstract] [Full Text] [Related]

  • 8. Prognosis of metachronous contralateral breast cancer according to stage at diagnosis: the importance of early detection.
    Schootman M, Fuortes L, Aft R.
    Breast Cancer Res Treat; 2006 Sep; 99(1):91-5. PubMed ID: 16555124
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Distinct breast cancer incidence and prognostic patterns in the NCI's SEER program: suggesting a possible link between etiology and outcome.
    Anderson WF, Jatoi I, Devesa SS.
    Breast Cancer Res Treat; 2005 Mar; 90(2):127-37. PubMed ID: 15803359
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Risk of contralateral testicular cancer: a population-based study of 29,515 U.S. men.
    Fosså SD, Chen J, Schonfeld SJ, McGlynn KA, McMaster ML, Gail MH, Travis LB.
    J Natl Cancer Inst; 2005 Jul 20; 97(14):1056-66. PubMed ID: 16030303
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Does multicentric/multifocal breast cancer differ from unifocal breast cancer? An analysis of survival and contralateral breast cancer incidence.
    Yerushalmi R, Kennecke H, Woods R, Olivotto IA, Speers C, Gelmon KA.
    Breast Cancer Res Treat; 2009 Sep 20; 117(2):365-70. PubMed ID: 19082705
    [Abstract] [Full Text] [Related]

  • 16. Second primary in the contralateral breast after treatment of breast cancer.
    Yadav BS, Sharma SC, Patel FD, Ghoshal S, Kapoor RK.
    Radiother Oncol; 2008 Feb 20; 86(2):171-6. PubMed ID: 17961777
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Primary and metastatic ovarian cancer in patients with prior breast carcinoma. Pre-operative markers and treatment results.
    Tserkezoglou A, Kontou S, Hadjieleftheriou G, Apostolikas N, Vassilomanolakis M, Sikiotis K, Salamalekis E, Tseke P, Magiakos G.
    Anticancer Res; 2006 Feb 20; 26(3B):2339-44. PubMed ID: 16821613
    [Abstract] [Full Text] [Related]

  • 20. Influence of young age at diagnosis and family history of breast or ovarian cancer on breast cancer outcomes in a population-based cohort study.
    Figueiredo JC, Ennis M, Knight JA, McLaughlin JR, Hood N, O'Malley F, Andrulis IL, Goodwin PJ.
    Breast Cancer Res Treat; 2007 Sep 20; 105(1):69-80. PubMed ID: 17115108
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.